Teva Tretinoin Capsules 10mg Recall: Failed Dissolution Testing
Teva Pharmaceuticals recalls 100-count Tretinoin Capsules (10mg) due to failed dissolution testing. This may affect medication effectiveness. Contact Teva for details.
Lower-risk recall
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
Contact the company
What happened, in plain English
Teva Pharmaceuticals is recalling 100-count Tretinoin Capsules (10mg) because they failed dissolution testing. This could mean the medication doesn't work as intended, so users should check if they have the specific lot number and contact Teva for guidance. Read more at govinfonow.com/recall/35392-teva-tretinoin-capsules-10mg-recall-failed-dissolution-testing.
Source Summary by GovInfoNow · govinfonow.com/recall/35392-teva-tretinoin-capsules-10mg-recall-failed-dissolution-testing · Updated August 18, 2026 · FDA enforcement record: FDA #D-0520-2022
Cite this page
“Teva Tretinoin Capsules 10mg Recall: Failed Dissolution Testing.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35392-teva-tretinoin-capsules-10mg-recall-failed-dissolution-testing. Based on FDA recall #D-0520-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0520-2022%22&limit=1).
Why it’s dangerous
The capsules failed dissolution testing, meaning they may not release the medication properly in the body. This could lead to the medication not working as intended, but it does not cause immediate harm or injury.
Who’s affected
People with prescriptions for Tretinoin Capsules (10mg) who received the specific lot number 100022970 from Teva Pharmaceuticals. Those using the medication for skin conditions like acne may be most affected.
How to tell if you have this one
Check for the product name 'Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only' with lot number 100022970. The expiration date is August 2022.
- Brand
Teva Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Identify if your capsule bottle has the lot number 100022970 and expiration date 08/2022.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0520-2022 (January 10, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0520-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.